BG
ARNA

BlackRock Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

BlackRock Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$314K Buy
22,075
+1,159
+6% +$18K ﹤0.01% 2518
2016
Q3 		$366K Sell
20,916
-31
-0.1% -$514 ﹤0.01% 2416
2016
Q2 		$358K Sell
20,947
-166
-0.8% -$2.97K ﹤0.01% 2376
2016
Q1 		$417K Buy
21,113
+2,960
+16% +$47.4K ﹤0.01% 2310
2015
Q4 		$345K Sell
18,153
-222
-1% -$4.53K ﹤0.01% 2348
2015
Q3 		$350K Buy
18,375
+1,297
+8% +$44K ﹤0.01% 2341
2015
Q2 		$793K Buy
17,078
+1,377
+9% +$59.7K ﹤0.01% 2078
2015
Q1 		$686K Buy
15,701
+940
+6% +$43.7K ﹤0.01% 2058
2014
Q4 		$512K Buy
14,761
+5,835
+65% +$237K ﹤0.01% 2222
2014
Q3 		$374K Sell
8,926
-110
-1% -$4.91K ﹤0.01% 2280
2014
Q2 		$530K Sell
9,036
-13,266
-59% -$835K ﹤0.01% 2174
2014
Q1 		$1.41M Buy
22,302
+433
+2% +$28.7K ﹤0.01% 1810
2013
Q4 		$1.28M Buy
21,869
+7,328
+50% +$383K ﹤0.01% 1829
2013
Q3 		$767K Buy
14,541
+696
+5% +$46.7K ﹤0.01% 2057
2013
Q2 		$1.07M Buy
+13,845
New +$1.13M ﹤0.01% 1708

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BlackRock Group's ARNA Position: Q4 2016 in Review

BlackRock Group increased its Arena Pharmaceuticals Inc (ARNA) stake by 5.5% in Q4 2016, buying an estimated $18K and bringing the position to 22,075 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2518.

BlackRock Group first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.41M in Q1 2014. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • BlackRock Group held 22,075 shares of Arena Pharmaceuticals Inc worth $314K as of Q4 2016.
  • BlackRock Group bought 1,159 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $18K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2518 holding.
  • BlackRock Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Arena Pharmaceuticals Inc position peaked at $1.41M in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.